{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:09:09Z","timestamp":1790410149516,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":1168,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000861","name":"Sparks","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["093,148\/Z\/10\/Z"],"award-info":[{"award-number":["093,148\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0801841"],"award-info":[{"award-number":["G0801841"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["UD99999906"],"award-info":[{"award-number":["UD99999906"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1194\/jlr.m073395","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T01:01:34Z","timestamp":1491354094000},"page":"1306-1314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease"],"prefix":"10.1016","volume":"58","author":[{"given":"Emmanuelle","family":"Lecommandeur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-7744","authenticated-orcid":false,"given":"Julian L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M073395_bib1","first-page":"454","article-title":"Chloroquine (SN-7618) pathologic changes observed in rats which for 2 years had been fed various proportions","volume":"45","author":"Nelson","year":"1948","journal-title":"Arch. Pathol. (Chic)."},{"key":"10.1194\/jlr.M073395_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1194\/jlr.M073395_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1194\/jlr.M073395_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9343(85)90346-8","article-title":"Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity","volume":"78","author":"Dake","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1194\/jlr.M073395_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1293\/tox.21.9","article-title":"Drug-induced phospholipidosis -pathological aspects and its prediction","volume":"21","author":"Nonoyama","year":"2008","journal-title":"J. Toxicol. Pathol."},{"key":"10.1194\/jlr.M073395_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol Pathol"},{"key":"10.1194\/jlr.M073395_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.taap.2014.06.014","article-title":"Di-22:6-bis(monoacylglycerol)phosphate: a clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment","volume":"279","author":"Liu","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20995-8","article-title":"Types of interaction of amphiphilic drugs with phospholipid vesicles","volume":"246","author":"Joshi","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1194\/jlr.M073395_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1388-1981(02)00361-X","article-title":"Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats","volume":"1631","author":"Mortuza","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02532199","article-title":"Bis-(monoacylglyceryl)phosphate and acyl phosphatidylglycerol isolated from human livers of lipidosis induced by 4,4\u2032-diethylaminoethoxyhexesterol","volume":"9","author":"Kasama","year":"1974","journal-title":"Lipids."},{"key":"10.1194\/jlr.M073395_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/32440","article-title":"A lipid associated with the antiphospholipid syndrome regulates endosome structure and function","volume":"392","author":"Kobayashi","year":"1998","journal-title":"Nature."},{"key":"10.1194\/jlr.M073395_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.cellbio.21.122303.120013","article-title":"Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids","volume":"21","author":"Kolter","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1194\/jlr.M073395_bib14","doi-asserted-by":"crossref","first-page":"27871","DOI":"10.1074\/jbc.M801463200","article-title":"Lysobisphosphatidic acid controls endosomal cholesterol levels","volume":"283","author":"Chevallier","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.plefa.2009.09.006","article-title":"Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: implications in pathology","volume":"81","author":"Hullin-Matsuda","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids."},{"key":"10.1194\/jlr.M073395_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/10084","article-title":"Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport","volume":"1","author":"Kobayashi","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1194\/jlr.M073395_bib17","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0006-2952(84)90286-7","article-title":"Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A","volume":"33","author":"Pappu","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib18","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/0006-2952(86)90662-3","article-title":"Binding of propranolol and gentamicin to small unilamellar phospholipid vesicles. Contribution of ionic and hydrophobic forces","volume":"35","author":"Kubo","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1194\/jlr.M073395_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1758-2946-4-2","article-title":"Predicting the mechanism of phospholipidosis","volume":"4","author":"Lowe","year":"2012","journal-title":"J. Cheminform."},{"key":"10.1194\/jlr.M073395_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-2952(87)90379-0","article-title":"Modifications of phospholipid metabolism induced by chlorpromazine, desmethylimipramine and propranolol in C6 glioma cells","volume":"36","author":"Leli","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-9861(86)90190-6","article-title":"Effects of lysosomotropic agents on lipogenesis","volume":"245","author":"Chen","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M073395_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1194\/jlr.M073395_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1034\/j.1600-0854.2000.010304.x","article-title":"Niemann-Pick type C mutations cause lipid traffic jam","volume":"1","author":"Liscum","year":"2000","journal-title":"Traffic."},{"key":"10.1194\/jlr.M073395_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-2275(20)39826-6","article-title":"Studies on drug-induced lipidosis: subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine or 4,4\u2032-bis (diethylaminoethoxy)alpha, beta-diethyldiphenylethane","volume":"21","author":"Matsuzawa","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M073395_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bcp.2011.07.090","article-title":"Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype","volume":"82","author":"Piccoli","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M073395_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/modpathol.3800344","article-title":"Chloroquine-induced lipidosis mimicking Fabry disease","volume":"18","author":"Albay","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1194\/jlr.M073395_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20071043","article-title":"Effect of lysosomal storage on bis(monoacylglycero)phosphate","volume":"411","author":"Meikle","year":"2008","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M073395_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1471-4159.2008.05497.x","article-title":"Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis","volume":"106","author":"Jabs","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.M073395_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","article-title":"Biochemical consequences of mutations causing the GM2 gangliosidoses","volume":"1455","author":"Mahuran","year":"1999","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib31","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1016\/S0021-9258(18)60406-5","article-title":"Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase","volume":"264","author":"Neufeld","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1432-1033.1985.tb08919.x","article-title":"Incorporation and metabolism of ganglioside GM2 in skin fibroblasts gangliosidosis subjects from normal and GM2","volume":"149","author":"Sonderfeld","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.M073395_bib33","doi-asserted-by":"crossref","first-page":"C1341","DOI":"10.1152\/ajpcell.1992.262.6.C1341","article-title":"Gangliosides as modulators of cell function","volume":"262","author":"Zeller","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.M073395_bib34","doi-asserted-by":"crossref","first-page":"506160","DOI":"10.5402\/2012\/506160","article-title":"Ganglioside biochemistry","volume":"2012","author":"Kolter","year":"2012","journal-title":"ISRN Biochem."},{"key":"10.1194\/jlr.M073395_bib35","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations and lipid storage in three variants of Tay-Sachs disease","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.M073395_bib36","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","article-title":"Sphingolipid metabolism diseases","volume":"1758","author":"Kolter","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00062-010-0035-4","article-title":"A case report of Sandhoff disease","volume":"21","author":"Saouab","year":"2011","journal-title":"Clin. Neuroradiol."},{"key":"10.1194\/jlr.M073395_bib38","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1073\/pnas.0603765103","article-title":"Effective gene therapy in an authentic model of Tay-Sachs-related diseases","volume":"103","author":"Cach\u00f3n-Gonz\u00e1lez","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M073395_bib39","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/hmg\/6.11.1879","article-title":"Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases","volume":"6","author":"Huang","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.M073395_bib40","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1093\/hmg\/ddr364","article-title":"Adeno-associated virus-mediated expression of \u03b2-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain","volume":"20","author":"Sargeant","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.M073395_bib41","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M073395_bib42","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.M073395_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9258(18)89718-6","article-title":"Chloroquine-induced phospholipid fatty liver","volume":"260","author":"Hostetler","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.M073395_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/nbm.740","article-title":"A comparison of cell and tissue extraction techniques using high-resolution 1 H-NMR spectroscopy","volume":"15","author":"Le Belle","year":"2002","journal-title":"NMR Biomed."},{"key":"10.1194\/jlr.M073395_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics."},{"key":"10.1194\/jlr.M073395_bib47","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1194\/jlr.M019174","article-title":"Electrospray MS\/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions","volume":"52","author":"Hutchins","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M073395_bib48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1194\/jlr.M800426-JLR200","article-title":"Cholesteryl esters as a depot for very long chain fatty acids in human meibum","volume":"50","author":"Butovich","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M073395_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib50","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/MCB.00627-06","article-title":"Lysosomal phospholipase A2 and phospholipidosis","volume":"26","author":"Hiraoka","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.M073395_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0192623311432290","article-title":"Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP","volume":"40","author":"Mesens","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1194\/jlr.M073395_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ceb.2004.06.004","article-title":"Membrane lipids and vesicular traffic","volume":"16","author":"van Meer","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1194\/jlr.M073395_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1194\/jlr.R200021-JLR200","article-title":"Lipid rafts: bringing order to chaos","volume":"44","author":"Pike","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M073395_bib54","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0006-3495(00)76399-5","article-title":"Different sphingolipids show differential partitioning into sphingolipid\/cholesterol-rich domains in lipid bilayers","volume":"79","author":"Wang","year":"2000","journal-title":"Biophys. J."},{"key":"10.1194\/jlr.M073395_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.biophys.093008.131357","article-title":"Lipids and cholesterol as regulators of traffic in the endomembrane system","volume":"39","author":"Lippincott-Schwartz","year":"2010","journal-title":"Annu. Rev. Biophys."},{"key":"10.1194\/jlr.M073395_bib56","doi-asserted-by":"crossref","first-page":"30271","DOI":"10.1074\/jbc.273.46.30271","article-title":"Degradation on vesicular membrane surfaces Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators","volume":"273","author":"Wilkening","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0962-8924(00)01847-X","article-title":"Jamming the endosomal system: lipid rafts and lysosomal storage diseases","volume":"10","author":"Simons","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1194\/jlr.M073395_bib58","doi-asserted-by":"crossref","first-page":"35814","DOI":"10.1074\/jbc.M006568200","article-title":"Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP","volume":"275","author":"Wilkening","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jat.2992","article-title":"Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment","volume":"35","author":"Bocchini","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1194\/jlr.M073395_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1194\/jlr.M073395_bib61","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M073395_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12017-010-8114-x","article-title":"The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases","volume":"12","author":"Ben-David","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1194\/jlr.M073395_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2008.12.010","article-title":"Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death","volume":"278","author":"Jana","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1194\/jlr.M073395_bib64","doi-asserted-by":"crossref","first-page":"42446","DOI":"10.1074\/jbc.M111.287383","article-title":"Alteration of ceramide synthase 6\/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER\/Golgi membrane network","volume":"286","author":"Senkal","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib65","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1096\/fj.09-135087","article-title":"Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6\/CHOP arm of ER-stress-response pathways","volume":"24","author":"Senkal","year":"2010","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M073395_bib66","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bbamem.2006.08.009","article-title":"Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy","volume":"1758","author":"Zheng","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib67","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0047-6374(01)00246-9","article-title":"Sphingomyelin and ceramide as regulators of development and lifespan","volume":"122","author":"Cutler","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1194\/jlr.M073395_bib68","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.bbamem.2011.07.023","article-title":"Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation","volume":"1808","author":"Pinto","year":"2011","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M073395_bib69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ejlt.200700024","article-title":"The functional role of sphingomyelin in cell membranes","volume":"109","author":"Slotte","year":"2007","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1194\/jlr.M073395_bib70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","article-title":"Chain length-specific properties of ceramides","volume":"51","author":"Gr\u00f6sch","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.1194\/jlr.M073395_bib71","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M073395_bib72","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1074\/jbc.M707386200","article-title":"Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate","volume":"283","author":"Laviad","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life."},{"key":"10.1194\/jlr.M073395_bib74","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/hmg\/ddr494","article-title":"Loss of ceramide synthase 3 causes lethal skin barrier disruption","volume":"21","author":"Jennemann","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.M073395_bib75","doi-asserted-by":"crossref","first-page":"30904","DOI":"10.1074\/jbc.M112.448852","article-title":"Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization","volume":"288","author":"Park","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M073395_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BJ20090699","article-title":"Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response","volume":"424","author":"Spassieva","year":"2009","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M073395_bib77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1194\/jlr.M009142","article-title":"Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism","volume":"52","author":"Mullen","year":"2011","journal-title":"J. Lipid Res."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520335823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520335823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M073395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T20:44:28Z","timestamp":1750193068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520335823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0022227520335823"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m073395","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.M073395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}